BS
BARER SOL J Other
US US · SEC (Form 4)
€247,644
▲ Purchases (5 ops.)
Browse the detailed record of transactions filed by BARER SOL J. Insider active across 2 companies, notably Teva Pharmaceutical Industries Ltd. Cumulatively, 12 filings have been logged. Total volume traded: €248k. The latest transaction was filed on 2 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations 12 total
25,791 shares
Ordinary Shares
SEC:0001209191-22-037243:0 · 14 Jun 2022
€42,879 20,720 shares @ €2.0695 6.1% of flow
Common Stock
SEC:0001209191-22-033727:0 · 2 Jun 2022
Ideal exit: 27 Feb 2023 (T+270) €24,165 10,000 shares @ €2.4165 3.4% of flow
Common Stock
SEC:0001209191-22-020914:0 · 23 Mar 2022
Ideal exit: 18 Dec 2022 (T+270) €65,625 30,000 shares @ €2.1875 9.3% of flow
Common Stock
SEC:0001209191-22-020766:0 · 22 Mar 2022
Ideal exit: 17 Dec 2022 (T+270) €58,027 30,000 shares @ €1.9342 8.2% of flow
Common Stock
SEC:0001209191-22-020522:0 · 21 Mar 2022
Ideal exit: 16 Dec 2022 (T+270) €56,948 30,000 shares @ €1.8983 8.1% of flow
Common Stock
SEC:0001209191-22-020256:0 · 18 Mar 2022
Ideal exit: 13 Dec 2022 (T+270) €229,217 50,000 shares @ €4.5843 100.0% of flow
Common Stock
SEC:0001209191-21-070879 · 21 Dec 2021
€229,217 50,000 shares @ €4.5843 32.5% of flow
Common Stock
SEC:0001209191-21-070879:0 · 21 Dec 2021
22,565 shares
Ordinary Shares
SEC:0001209191-21-039367:0 · 9 Jun 2021
22,565 shares
Ordinary Shares
SEC:0001209191-21-039367 · 9 Jun 2021
17,565 shares
Ordinary Shares
SEC:0001209191-21-038811 · 5 Jun 2021
17,565 shares
Ordinary Shares
SEC:0001209191-21-038811:0 · 5 Jun 2021
About BARER SOL J Sol J Barer is a director at Teva Pharmaceutical Industries Ltd and NexImmune, Inc.